Filter by:
Cardiovascular
March 2026
American College of Cardiology Scientific Session & Expo
Reduced cardiac stress and inflammatory proteomic signatures in obstructive and nonobstructive HCM following EDG-7500 treatment in CIRRUS-HCM
Cardiovascular
January 2026
Cardiometabolism in Health and Disease
Chronic EDG-7500 treatment prevents left atrial metabolic dysfunction in a Yucatan mini-pig model of genetic non-obstructive hypertrophic cardiomyopathy
Cardiovascular
December 2025
CVCT
CIRRUS-HCM: A Multiple-Dose Phase 2 Study of Safety, Tolerability, and Effects on Hemodynamics and Functional Capacity of the Novel Cardiac Sarcomere Modulator EDG-7500 in Hypertrophic Cardiomyopathy
Cardiovascular
September 2025
International Workshop on Cardiomyopathies
Plenary Presentation: CIRRUS-HCM: A Multiple-Dose Phase 2 Study of Safety, Tolerability, and Effects and Functional Capacity of the Novel Cardiac Sarcomere Modulator EDG-7500 in Hypertrophic Cardiomyopathy
Cardiovascular
September 2025
International Workshop on Cardiomyopathies
EDG-7500 in Hypertrophic Cardiomyopathy
Cardiovascular
September 2025
International Workshop on Cardiomyopathies
CIRRUS-HCM: A Multiple-Dose Phase 2 Study of Safety, Tolerability, and Effects on Hemodynamics and Functional Capacity of the Novel Cardiac Sarcomere Modulator EDG-7500 in Hypertrophic Cardiomyopathy
Cardiovascular
May 2025
ASCPT Annual Meeting
Pharmacokinetics of EDG-7500, a First-in-Class Cardiac Sarcomere Modulator for the Treatment of Hypertrophic Cardiomyopathy
Cardiovascular
May 2025
Heart Failure & World Congress on Acute Heart Failure
CIRRUS-HCM: A Multiple-Dose Phase 2 Study of Safety, Tolerability, and Effects on Hemodynamics and Functional Capacity of the Novel Cardiac Sarcomere Modulator EDG-7500 in Hypertrophic Cardiomyopathy
Cardiovascular
December 2024
Global CVCT Forum
